Exploiting B Cell Transfer for Cancer Therapy: Engineered B Cells to Eradicate Tumors

Nowadays, cancers still represent a significant health burden, accounting for around 10 million deaths per year, due to ageing populations and inefficient treatments for some refractory cancers. Immunotherapy strategies that modulate the patient’s immune system have emerged as good treatment options...

Descripción completa

Detalles Bibliográficos
Autores principales: Page, Audrey, Hubert, Julie, Fusil, Floriane, Cosset, François-Loïc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468294/
https://www.ncbi.nlm.nih.gov/pubmed/34576154
http://dx.doi.org/10.3390/ijms22189991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468294/
https://www.ncbi.nlm.nih.gov/pubmed/34576154
http://dx.doi.org/10.3390/ijms22189991

Ejemplares similares